An FDA announcement that semaglutide injection products, the GLP-1 medication in the blockbuster drugs Wegovy and Ozempic, are no longer in shortage
It is crucial that all patients with T2D treated with GLP-1 RAs, regardless of preexisting DR, receive regular screening and monitoring for potential complications of T2D
Saiyasit N, Chunchai T, Jaiwongkam T, Kerdphoo S, Apaijai N, Pratchayasakul W, et al
LL-37 is a reminder that the human body is not a passive host waiting for infections to be treated
whilst it may influence redox status, it is not a direct glutathione precursor or building block
Understanding what drug screens actually detectand why tirzepatide isn't among themcan provide reassurance for patients undergoing employment testing, pre-operative screening, or routine clinical assessments while using this FDA-approved prescription therapy